medigraphic.com
Revista Médica Sinergia

2023, Número 03

<< Anterior Siguiente >>

Revista Médica Sinergia 2023; 8 (03)


Síndrome de Budd-Chiari: abordaje y manejo

Cesare PS, Murillo BF, Obaldía MAP

Idioma: Español
Referencias bibliográficas: 15
Paginas:
Archivo PDF: 181.11 Kb.


RESUMEN

El síndrome de Budd-Chiari se cataloga dentro de las enfermedades poco frecuentes, con una incidencia de 0.45 por cada millón de personas. Consiste en una obstrucción al flujo venoso hepático que obedece a múltiples etiologías, más comúnmente a una trombosis venosa, generando una congestión hepática con aumento de presión venosa portal, produciendo así fibrosis y eventualmente falla hepática. Su manejo se orienta en revertir la obstrucción, mejorado el flujo sanguíneo y la perfusión para preservar la función del órgano.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lupasco I, Dumbrava VT. Diagnosis and therapy of Budd Chiari syndrome. Med Pharm Rep [Internet]. 2021;94(Suppl No 1):S68–71. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/34527916%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8411809

  2. Sh. Hassan AA, Alsaleh ME, Alsaleh ME, al Zaher FA, Almajed FA, Alkhudhair AM, et al. Budd-Chiari Syndrome: A Case Report of a Rare Presentation of COVID-19. Cureus. 2021;13(1):7-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863030/

  3. Alukal JJ, Zhang T, Thuluvath PJ. A Nationwide Analysis of Budd–ChiariSyndrome in the United States. J Clin Exp Hepatol [Internet]. 2021;11(2):181–7. DOI: https://doi.org/10.1016/j.jceh.2020.08.005

  4. Pérez-González A, Argibay A, Lorenzo-Castro R, Martín-Granizo I, Rivera-Gallego A. Budd-Chiari syndrome: epidemiological and clinical characteristics of a case series in Northwest Spain. Egyptian Liver Journal [Internet]. 2022;12(1):1–7. DOI: https://doi.org/10.1186/s43066-022-00192-1

  5. Iliescu L, Toma L, Mercan-Stanciu A, Grumeza M, Dodot M, Isac T, et al. Budd-Chiari syndrome - various etiologies and imagistic findings. A pictorial review. Med Ultrason. 2019;21(3):344–8. DOI: https://doi.org/10.11152/mu-1921

  6. Gavriilidis P, Marangoni G, Ahmad J, Azoulay D. State of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review. J Clin Med Res [Internet]. 2022;14(4):147-57. DOI: https://www.doi.org/10.14740/jocmr4724

  7. Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL) [Internet]. Hepatology International. Springer India; 2021;15:531-567. DOI: https://doi.org/10.1007/s12072-021-10189-4

  8. Hernández-Gea V, de Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol [Internet]. 2019;71(1):175–99. DOI: https://doi.org/10.1016/j.jhep.2019.02.015

  9. Stanciugelu A, Petrică A, Chiriac SDAN, Iurciuc M, Boruga MV, Balica N, et al. A rare encounter with two cases of Budd - Chiari syndrome in the Emergency Department: A case report. Exp Ther Med [Internet]. 2022;24(730):1–5. DOI: https://doi.org/10.3892/etm.2022.11666

  10. Mancuso A. Budd – Chiari Syndrome Management: Controversies and Open Issues. Diagnostics [Internet]. 2022;12(11). Disponible en: https://www.mdpi.com/2075-4418/12/11/2670#cite

  11. Wester A, Åberg F, Rajani R, Hagström H. Minimal risk of hepatocellular carcinoma in non-cirrhotic Budd-Chiari syndrome: A three-decade population-based study. Clinical Gastroenterology and Hepatology [Internet]. 2022;(October):6-9. DOI: https://doi.org/10.1016/j.cgh.2022.08.042

  12. Aktas H, Ozer A, Yilmaz TU, Keceoglu S, Can MG, Emiroglu R. Liver transplantation for Budd-Chiari syndrome: A challenging but handable procedure. Asian J Surg [Internet]. 2022;45(7):1396–402. DOI: https://doi.org/10.1016/j.asjsur.2021.09.007

  13. Garmpis N, Damaskos C, Prevezanos D, Garmpi A, Georgakopoulou V, Antoniou E, et al. Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution. MAEDICA – a Journal of Clinical Medicine [Internet]. 2022;17(2):415-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375878/

  14. Das CJ, Soneja M, Tayal S, Chahal A, Srivastava S, Kumar A, et al. Role of radiological imaging and interventions in management of Budd–Chiari syndrome. Clin Radiol [Internet]. 2018;73(7):610–24. DOI: https://doi.org/10.1016/j.crad.2018.02.003

  15. Artru, Florent. Moschouri, Eleni. Denys Alban. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosistemic shunt (TTIPS) to treat complications of portal hypertension: Indication, technique, and outcomes beyond Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol [Internet]. 2022;46(4):1-16. Disponible en: https://www.sciencedirect.com/science/article/pii/S2210740122000018#section-cited-by




2020     |     www.medigraphic.com